IBSA Pharma is part of IBSA Group, headquartered in Lugano, Switzerland, a world leader in the treatment of acute pain and treatment of hypothyroidism. IBSA distributes Licart™ (diclofenac epolamine) topical system 1.3%, a unique patent patch technology for the relief of acute pain associated with minor strains, sprains, and contusions.